IAIM
INO icon

International Assets Investment Management’s Inovio Pharmaceuticals INO Stock Holding History

International Assets Investment Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43 Hold
36
– – ﹤0.01% 2338
2026
Q1 		$63 Hold
36
– – ﹤0.01% 2222
2025
Q4 		$63 Buy
+36
New +$79 ﹤0.01% 2179
2024
Q3 		– Sell
-94
Closed -$760 – 2203
2024
Q2 		$760 Buy
+94
New +$989 ﹤0.01% 2138
2021
Q4 		– Sell
-895
Closed -$77K – 550
2021
Q3 		$77K Hold
895
– – 0.01% 491
2021
Q2 		$100K Sell
895
-1,110
-55% -$107K 0.02% 476
2021
Q1 		$219K Buy
2,005
+1,100
+122% +$145K 0.02% 497
2020
Q4 		$96K Buy
+905
New +$120K 0.02% 609
2020
Q3 		– Sell
-997
Closed -$322K – 415
2020
Q2 		$322K Buy
997
+147
+17% +$23.6K 0.08% 225
2020
Q1 		$76K Buy
+850
New +$52.4K 0.02% 330

Other funds holding INO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $149M AUM 118.1% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.74B AUM 36.19% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

International Assets Investment Management's INO Position: Q2 2026 in Review

International Assets Investment Management held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 36 shares worth $43. The position accounts for ﹤0.01% of the portfolio, ranked #2338.

International Assets Investment Management first reported a position in INO in Q1 2020 and has held it in 10 quarters since. The position peaked at $322K in Q2 2020. 57 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • International Assets Investment Management held 36 shares of Inovio Pharmaceuticals worth $43 as of Q2 2026.
  • International Assets Investment Management left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #2338 holding.
  • International Assets Investment Management first reported a position in Inovio Pharmaceuticals in Q1 2020 and has held it in 10 quarters since.
  • International Assets Investment Management's Inovio Pharmaceuticals position peaked at $322K in Q2 2020.
  • 57 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.